Myelofibrosis Treatment Market Size In 2022 with Top Countries Data : What are the major factors impacting Industry growth during the forecast period? | In-Depth Analysis with 99 Report Pages

(The Express Wire via Comtex)

Myelofibrosis Treatment Market In 2022 (Short Description) : Myelofibrosis or osteomyelofibrosis is a myeloproliferative disorder which is characterized by proliferation of abnormal clone of hematopoietic stem cells. Myelofibrosis is a rare type of chronic leukemia which affects the blood forming function of the bone marrow tissue. The disorder is found to occur mainly in the people of age 50 or more and shows no symptoms at an early stage. The common symptoms associated with myelofibrosis include weakness, fatigue, anemia, splenomegaly (spleen enlargement) and gout. However, the disease progresses very slowly and 10% of the patients eventually develop acute myeloid leukemia. Treatment options for myelofibrosis are mainly to prevent the complications associated with low blood count and splenomegaly.https://www.360researchreports.com/enquiry/request-sample/20718594

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Myelofibrosis Treatment Market Size In 2022 with Top Countries Data : What are the major factors impacting Industry growth during the forecast period? | In-Depth Analysis with 99 Report Pages

comtex tracking

COMTEX_409154187/2598/2022-06-24T03:34:12